Form 4 for GRDN Guardian Pharmacy Services, Inc.
Accepted 2025-09-30 00:00:00 ET · period of report 2025-09-27 · accession 0001193125-25-225030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-09-30 | 2025-09-27 | GRDN | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | +6.10M | 8.04M | +314% | — |
| DI | 2025-09-30 | 2025-09-27 | GRDN | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | -6.10M | 12.20M | -33% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-27 | M | A | 6,100,176 | — | 8,039,993 | I By Bindley Capital Partners I, LLC | — | — | (F1) Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. |
| 2 | Derivative | Class B Common Stock | 2025-09-27 | M | D | 6,100,176 | — | 12,200,350 | I By Bindley Capital Partners I, LLC | — · — to — | 6,100,176 Class A Common Stock | (F1) Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026. |